These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15049403)

  • 21. Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol.
    Meyrier A
    Br Med J; 1976 Aug; 2(6033):458. PubMed ID: 953607
    [No Abstract]   [Full Text] [Related]  

  • 22. Carboplatin desensitization.
    Choi J; Harnett P; Fulcher DA
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):137-41. PubMed ID: 15328672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
    Dalbeth N; Stamp L
    Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clopidogrel desensitization after drug-eluting stent placement.
    von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
    J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.
    Gutiérrez-Macías A; Lizarralde-Palacios E; Martínez-Odriozola P; Miguel-De la Villa F
    BMJ; 2005 Sep; 331(7517):623-4. PubMed ID: 16166134
    [No Abstract]   [Full Text] [Related]  

  • 28. Allopurinol-induced DRESS syndrome.
    Markel A
    Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
    Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
    Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypersensitivity syndrome caused by allopurinol (personal case and a review of the literature)].
    Shukurova SM
    Revmatologiia (Mosk); 1987; (3):56-9. PubMed ID: 3317716
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allopurinol hypersensitivity: investigating the cause and minimizing the risk.
    Stamp LK; Day RO; Yun J
    Nat Rev Rheumatol; 2016 Apr; 12(4):235-42. PubMed ID: 26416594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The usefulness of the desensitization to rifampin in the treatment of mycobacterial disease in patients with AIDS].
    Arrizabalaga J; Casas A; Camino X; Iribarren JA; Rodríguez Arrondo F; Von Wichmann MA
    Med Clin (Barc); 1998 Jun; 111(3):103-4. PubMed ID: 9706604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.
    Ramasamy SN; Korb-Wells CS; Kannangara DR; Smith MW; Wang N; Roberts DM; Graham GG; Williams KM; Day RO
    Drug Saf; 2013 Oct; 36(10):953-80. PubMed ID: 23873481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case reports of evaluation and desensitization for anti-thymocyte globulin hypersensitivity.
    Millar MM; Grammer LC
    Ann Allergy Asthma Immunol; 2000 Oct; 85(4):311-6. PubMed ID: 11061475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic reaction to allopurinol with cross-reactivity to oxypurinol.
    Lockard O; Harmon C; Nolph K; Irvin W
    Ann Intern Med; 1976 Sep; 85(3):333-5. PubMed ID: 134655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent control of hyperuricemia in the treatment of gout.
    Bull PW; Scott JT
    J Rheumatol; 1989 Sep; 16(9):1246-8. PubMed ID: 2681764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.